VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UNCY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
UNCYUnicycive Therapeutics, Inc.
$7.70$1.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksUNCYQuarterly Financials

Unicycive Therapeutics, Inc. (UNCY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Unicycive Therapeutics, Inc. (UNCY) quarterly income statement — complete revenue, gross profit & net income history

UNCY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000000675K0951K00000
Revenue Growth %---------100%--100%---------
Cost of Goods Sold211K0000000284K00000000000
COGS % of Revenue--------------------
Gross Profit-211K0000000-284K000675K0951K00000
Gross Margin %------------100%-100%-----
Gross Profit Growth %----100%----142.07%--100%---------
Operating Expenses8.23M7.22M7.34M6.96M7.99M9.26M6.25M7.4M8.92M6.31M5.94M4.32M4.88M5.33M6.5M3.64M3.54M2.75M4.71M779K
OpEx % of Revenue------------722.52%-684.02%-----
Selling, General & Admin6.83M4.97M4.38M5.21M5.82M3.97M3.21M2.53M2.11M2.08M2.57M2.06M1.85M1.49M1.7M1.78M1.6M1.39M939K286K
SG&A % of Revenue------------273.63%-178.97%-----
Research & Development1.61M2.25M2.96M1.75M2.17M5.29M3.04M4.87M6.81M4.23M3.37M2.27M3.03M3.84M4.8M1.86M1.93M1.36M3.78M493K
R&D % of Revenue------------448.89%-505.05%-----
Other Operating Expenses-211K0000000000000000000
Operating Income-8.44M-7.22M-7.34M-6.96M-7.99M-9.26M-6.25M-7.4M-9.2M-6.31M-5.94M-4.32M-4.2M-5.33M-5.55M-3.64M-3.54M-2.75M-4.71M-779K
Operating Margin %-------------622.52%--584.02%-----
Operating Income Growth %-5.61%22%-17.45%5.92%13.2%-46.7%-5.27%-71.24%-119.04%-18.55%-6.91%-18.87%-18.8%-93.5%-17.79%-366.75%-383.86%-283.82%-653.19%-131.85%
EBITDA-8.23M-7.07M-7.19M-6.83M-7.85M-9.25M-6.13M-7.4M-8.92M-6.31M-5.86M-4.24M-4.16M-5.32M-5.51M-3.6M-3.5M-2.75M-5.15M0
EBITDA Margin %-------------615.85%--579.81%-----
EBITDA Growth %-4.74%23.57%-17.4%7.78%11.95%-46.66%-4.59%-74.39%-114.58%-18.54%-6.26%-18.02%-18.84%-93.44%-7.15%--391.29%---
D&A (Non-Cash Add-back)211K151K148K138K135K7K123K0284K3K79K78K45K2K40K40K39K2500779K
EBIT-8.44M-14.64M-6M-6.43M585K-9.26M-4.08M-7.4M-20.94M-6.31M-4.32M-3.81M-14.56M-5.33M-5.55M-3.64M-3.54M-2.75M-5.15M-779K
Net Interest Income394K324K264K142K211K294K401K446K49K121K209K202K2K-3K-3K000-55K-321K
Interest Income394K351K279K155K226K314K416K462K69K140K227K234K14K0000000
Interest Expense027K15K13K15K20K15K16K20K19K18K32K12K3K3K00055K321K
Other Income/Expense-4.39M-7.44M1.33M516K8.56M-12.26M2.15M17.26M-11.76M-1.49M1.6M484K-10.37M-3K-3K000-486K-321K
Pretax Income-12.82M-14.67M-6.01M-6.45M570K-21.52M-4.1M9.86M-20.96M-7.8M-4.33M-3.84M-14.57M-5.33M-5.56M-3.64M-3.54M-2.75M-5.2M-1.1M
Pretax Margin %-------------2159.26%--584.33%-----
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-12.82M-14.67M-6.01M-6.45M570K-21.52M-4.1M9.86M-20.96M-7.8M-4.33M-3.84M-14.57M-5.33M-5.56M-3.64M-3.54M-2.75M-5.2M-1.1M
Net Margin %-------------2159.26%--584.33%-----
Net Income Growth %-2349.65%31.86%-46.75%-165.42%102.72%-176.03%5.47%356.77%-43.83%-46.36%22.03%-5.56%-312.07%-93.6%-6.84%-230.55%-266.91%-212.73%-640.88%-225.44%
Net Income (Continuing)-12.82M-14.67M-6.01M-6.45M570K-21.52M-4.1M9.86M-20.96M-7.8M-4.33M-3.84M-14.57M-5.33M-5.56M-3.64M-3.54M-2.75M-5.2M-1.1M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.54-0.32-0.33-0.52-0.50-2.00-0.46-0.15-6.00-0.22-0.13-0.25-1.65-0.35-0.37-0.24-0.24-0.19-0.37-0.08
EPS Growth %-7.57%84%28.26%-246.67%91.63%-809.09%-253.85%40%-263.64%37.14%64.86%-4.17%-587.5%-84.21%0%-204.96%-118.18%-213.01%-351.77%-99.75%
EPS (Basic)-0.54-0.66-0.33-0.520.04-2.00-0.460.08-6.00-0.22-0.13-0.25-1.65-0.35-0.37-0.24-0.24-0.19-0.37-0.08
Diluted Shares Outstanding239.08M158.87M18.07M12.3M12.38M6.7M8.89M9.41M3.49M3.48M3.26M1.52M1.52M1.52M1.51M1.5M1.5M1.42M14.17M1.4M
Basic Shares Outstanding239.08M158.87M18.07M12.3M11.68M6.7M8.89M3.79M3.49M3.48M3.26M1.52M1.52M1.52M1.51M1.5M1.5M1.42M14.17M1.4M
Dividend Payout Ratio-------11.11%------------